Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Sarcoma, Kaposi 4Sarcoma 3Stomach Neoplasms 1Skin Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liposarcoma 1Hodgkin Disease 1HIV Infections 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Castleman Disease 1AIDS-related Kaposi sarcoma 1AIDS-Related Opportunistic Infections 1

Interventions

Specimen Handling 2Semaxinib 2tin etiopurpurin 1pembrolizumab 1montanide ISA 51 1cc-486 1atezolizumab 1Tumor Necrosis Factor-alpha 1Tissue Banks 1SUB1 protein, human 1Ritonavir 1Radiosurgery 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Nelfinavir 1Molecular Diagnostic Techniques 1Mohs Surgery 1Melphalan 1Interleukin-2 1Interleukin-12 1Injections 1Immunotherapy 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Blood Specimen Collection 1Biopsy 1Biological Therapy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Nelfinavir × Sarcoma × Clear all
NCT00002185 2005-06-24

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
20 enrolled
DermatologicSarcoma

Sarcoma, Kaposi, Skin Neoplasms, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡